MNKD partnership could put 1st year sales in Billions with sales to both types of Diabetes.
Its is amazing to realize that Type I and Type collectively will bring in sales in the billions especially i MNKD partners. Ist year sales could see 2 Bills, 2nd Year 4 Bills, and beyond can bring in 6 Bills per year for sales of Afrezza to the entire global Population. Partnership is needed to mass produce afreeza towards the Diabetic market globally. I woul predict that Big Pharma's will not allow MNKD to exist as company and to target the Diabetic market . They will grab afreeza even at $15.00. This is a winner for many years. Very safe , cheap cost and easy to use. I suspect that someone will but this company when results gets published next month.
$15 (~$7billion) is way too cheap. Many here are underestimating the buyout price of MNKD. Amylin was bought out for $7billion and Afrezza will be a much much much bigger blockbuster. Not trying to pump, just giving my observations IF mnkd is bought out.
phoqoo, Big pharma's got to make a profit too. It was why so cheap. Why would they buy something and not make at least a 100% profit? The Big Pharmas goal is to corner the Diabetic market and be the sole owner , distributor and money maker.
If the outcomes are very strong, and there is research behind this drug and drug system, then yes probably you are correct, however if the evidence is kind of weak, but still passes, there could be adjustments along the way in Phase IV, which could keep valuations more conservative.
However if it was $ 10 Billion, that would mean the share price is around $ 50.00 per share would it not ?